Ads
related to: Therapy Notes
Search results
Intra-Cellular Therapies (NASDAQ:ITCI) Trading Down 2.7%
ETF DAILY NEWS· 16 hours agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report)’s share price was down 2.7% during mid-day trading on Wednesday . The company traded as low as $76.50 and last traded at $77.66 ...
Cell Therapy Treatment Effectively Treats Immune-Compromised Children
Technology Networks· 23 hours agoThis new treatment uses blood from healthy donors to manufacture a highly specialized immune therapy...
Tinnitus retraining therapy: Procedure, effectiveness, and risks
Medical News Today· 3 days agoTinnitus retraining therapy (TRT) uses counseling and sound therapy to alter a negative response to...
The Goldman Sachs Group Increases Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $77.00
ETF DAILY NEWS· 2 days agoThe Goldman Sachs Group currently has a neutral rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the stock. Needham & ...
ADUS vs. USPH: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 7 hours agoPhysical Therapy has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently...
Long Island boy with rare blood disorder undergoes gene therapy
WPIX 11 New York· 23 hours agoLONG ISLAND, N.Y. (PIX11) — Until now, the best treatment for some diseases has been bone marrow...
15 Sex Dreams’ Meanings, According to Dream Experts
Glamour via Yahoo News· 7 hours agoElyssa Helfer, an AASECT-certified sex therapist and the founder of the Center for Relational Therapy. She also notes that some people can lucid dream,...
Valley Stream boy, 8, is first in New York State to receive new therapy for blood disorder
Newsday· 14 hours agoYusef Saeed, of Valley Stream, received on Jan. 9 an infusion of Zynteglo gene therapy at Cohen...
Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $90.00 by Analysts at TD Cowen
ETF DAILY NEWS· 2 days agoIntra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its price objective hoisted by TD Cowen from $80.00 to $90.00 in a report issued on Wednesday morning, Benzinga reports. They currently ...
Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer, finds study
Medical Xpress· 2 days agoFor patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels ...
Ads
related to: Therapy Notes10.0/10 (1918 reviews)
